Indole derivatives as CRTH2 receptor antagonists

Details for Australian Patent Application No. 2010218209 (hide)

Owner Merck Canada Inc. Merck Sharp & Dohme Corp.

Inventors Berthelette, Carl; Boyd, Michael; Colucci, John; Villeneuve, Karine; Methot, Joey

Agent Spruson & Ferguson

Pub. Number AU-A-2010218209

PCT Pub. Number WO2010/099039

Priority 61/154,968 24.02.09 US

Filing date 19 February 2010

Wipo publication date 2 September 2010

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/405 (2006.01)

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/099039 Priority application(s): WO2010/099039

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Canada Inc.; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010218224-Soluble guanylate cyclase activators

2010218207-Selectable presentation of dual-bin system